Clinical Trial 56084

Skokie, IL 60077


Phase 3 study involving GLP agonist like Ozempic plus second agent vs Monjuaro as add on therapy to metformin plus or minus jardiance or farxiga in patients with type 2 diabetes who are not adequately controlled on current therapy.  The study will last 76 weeks.   


Have Type 2 Diabetes 

Hemoglobin  A1c greater than 7.0 

BMI greater than 27

On Metformin plus or minus Jardaince or Farxiga 

Qualified Participants May Receive:

Compensation for time 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.